Trexquant Investment’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-260,157
Closed -$1.81M 1573
2025
Q3
$1.81M Sell
260,157
-388,881
-60% -$2.74M 0.02% 941
2025
Q2
$3.84M Sell
649,038
-211,208
-25% -$1.21M 0.04% 635
2025
Q1
$5.5M Buy
860,246
+459,582
+115% +$4.43M 0.06% 465
2024
Q4
$4.76M Buy
+400,664
New +$6.83M 0.06% 541
2024
Q3
Sell
-179,276
Closed -$4.28M 1523
2024
Q2
$4.28M Buy
179,276
+76,846
+75% +$1.8M 0.07% 460
2024
Q1
$1.8M Buy
+102,430
New +$1.51M 0.04% 695
2023
Q2
Sell
-96,920
Closed -$722K 1420
2023
Q1
$722K Buy
+96,920
New +$963K 0.02% 857

Other funds holding ASPN

Trexquant Investment's ASPN Position: Q4 2025 in Review

Trexquant Investment sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 260,157 shares — an estimated $1.81M sold.

Trexquant Investment first reported a position in ASPN in Q1 2023 and held it in 7 quarters. The position peaked at $5.5M in Q1 2025. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Trexquant Investment reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 260,157 Aspen Aerogels shares in Q4 2025, an estimated $1.81M.
  • Trexquant Investment first reported a position in Aspen Aerogels in Q1 2023 and held it in 7 quarters.
  • Trexquant Investment's Aspen Aerogels position peaked at $5.5M in Q1 2025.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.